Characteristics of abnormal menstrual cycle and polycystic ovary syndrome in community and hospital populations

( views:97, downloads:0 )
Author:
MA Yan-min(Reproductive Medical Centre, Peking University Third Hospital,Beijing 100191, China;Reproductive Medical Centre, Beijing Obstetrics and Gynecology Hospital Affiliated of Capital Medical University, Beijing 100026,China)
LI Rong(Reproductive Medical Centre, Peking University Third Hospital,Beijing 100191, China)
QIAO Jie(Reproductive Medical Centre, Peking University Third Hospital,Beijing 100191, China)
ZHANG Xiao-wei(Department of Genetics, Reproductive Medical Centre, Peking University Third Hospital, Beijing 100191, China)
WANG Shu-yu(Reproductive Medical Centre, Beijing Obstetrics and Gynecology Hospital Affiliated of Capital Medical University, Beijing 100026,China)
ZHANG Qiu-fang(Reproductive Medical Centre, Peking University Third Hospital,Beijing 100191, China)
LI Li(Reproductive Medical Centre, Peking University Third Hospital,Beijing 100191, China)
TU Bin-bin(Reproductive Medical Centre, Peking University Third Hospital,Beijing 100191, China)
ZHANG Xue(Reproductive Medical Centre, Peking University Third Hospital,Beijing 100191, China)
Journal Title:
CHINESE MEDICAL JOURNAL
Issue:
Volume 123, Issue 16, 2010
DOI:
10.3760/cma.j.issn.0366-6999.2010.16.005
Key Word:
polycystic ovary syndrome;menstrual cycle;community;hospital

Abstract: Background Polycystic ovary syndrome (PCOS) is considered to be the most common endocrine disorder in women of reproductive age.The involvement of an abnormal menstrual cycle in the etiology of PCOS remains unclear.We aimed to analyze the characteristics of abnormal menstrual cycles and their association with PCOS in community and hospital patient populations.Methods Women with PCOS identified from 2111 permanent female residents in the community of Beijing and 506 outpatients obtained from the reproductive clinic of Peking University Third Hospital were recruited for this study,comprising the PCOS community group and the PCOS hospital group, respectively.Each group was further divided into four subgroups according to the length of menstrual cycles: <21 days; 21-34 days; 35-60 days; and >60 days.Women in each group were interviewed using a questionnaire to assess factors including age, age of menarche, menstrual cycle history, related family history, and modified Ferriman-Gallwey (mF-G) score.All women received transvaginal ultrasound scan and had fasting blood samples taken for endocrine evaluation.A two-tailed P value of <0.05 was considered significant.Results In the community population, the prevalence of abnormal menstrual cycle was 27.19% (574/2111).The prevalence of PCOS in the community was 6.11% (129/2111) according to Rotterdam criteria.In the community group,the most common menstrual cycle length was 35-60 days, whereas for the hospital group, it was >60 days.In both the community and hospital groups, the most common phenotype of PCOS was that of Oligo/amenorrhea+PCO+hyperandrogenism (HA) (O+P+H) (P=0.000).With increasing cycle length of 35-60 days to >60 days, the percentages of Oligo/amenorrhea+PCO (O+P) and O+P+H were found to significantly decrease in the community group and significantly increase in the hospital group (P=0.000 for each).In the hospital group, as the menstrual cycle length increased from 35-60 days to >60 days, the rate of spontaneous abortion increased significantly (P=0.000), meanwhile the rate of poorly-secreted endometrium and abnormal endometrial hyperplasia increased significantly (P=0.000).Conclusions The prevalence of PCOS in the Beijing community of women was 6.11%.Oligo/arnenorrhea was the most common type of abnormal menstrual cycle and may be an indicator for PCOS and endometrial lesions.Gynecologists should seek relevant medical information from women in the community to promptly diagnose PCOS and then follow up patients for potential development of subsequent complications.

  • [1]Knochenhauer ES,Key TJ,Kahsar-Miller M,Waggoner W,Boots LR,Azziz R.Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States:a prospective study.J Clin Endocrinol Metab 1998; 83:3078-3082.
  • [2]Rudnicka,E.,W.Wierzba,and S.Radowicki.Evaluation of endometrial histologic morphology in patients with polycystic ovary syndrome.Ginekol Pol 2009; 80:103-106.
  • [3]Chittenden BG,Fullerton G,Maheshwari A,Bhattacharya S.Polycystic ovary syndrome and the risk of gynaecological cancer:a systematic review.Reprod Biomed Online 2009; 19:398-405.
  • [4]Sharma ST,Nestler JE.Prevention of diabetes and cardiovascular disease in women with PCOS:treatment with insulin sensitizers.Best Pract Res Clin Endocrinol Metab 2006; 20:245-260.
  • [5]Iatrakis G,Tsionis C,Adonakis G,Stoikidou M,Anthouli-Anagnostopoulou F Parava M.Polycystic ovarian syndrome,insulin resistance and thickness of the endometrium.Eur J Obstet Gynecol Reprod Biol 2006; 127:218-221.
  • [6]Shen ZQ,Zhu HT,Lin JF.Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives.Obstet Gynecol 2008; 112(2 Pt 2):465-467.
  • [7]Strowitzki T,Capp E,von Eye Corleta H.The degree of cycle irregularity correlates with the grade of endocrine and metabolic disorders in PCOS patients.Eur J Obstet Gynecol Reprod Bio12010; 149:178-181.
  • [8]Hahn S,Tan S,Elsenbruch S,Quadbeck B,Herrmann BL,Mann K.Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia.Horm Metab Res 2005; 37:438-444.
  • [9]Dewailly D.The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome:the complete task force report.Fertil Steril 2009; 91:456-488.
  • [10]Balen AH,Laven JS,Tan SL,Dewailly D.Ultrasound assessment of the polycystic ovary:international consensus defmitions.Hum Reprod Update 2003; 9:505-514.
  • [11]March WA,Moore VM,Willson KJ,Phillips DI,Norman RJ,Davies MJ.The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.Hum Reprod 2010; 25:544-551.
  • [12]Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Hum Reprod 2004; 19:41-47.
  • [13]Norman RJD,Legro D,Hickey RS.Polycystic ovary syndrome.Lancet 2007; 370:685-697.
  • [14]Kumarapeli V,Seneviratne Rde,Wijeyaratne A,Yapa CN,Dodampahala RM.A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.Am J Epidemiol 2008; 168:321-318.
  • [15]Chen X,Yang D,Mo Y,Li L,Chen Y,Huang Y.Prevalence of polycystic ovary syndrome in unselected women from southern China.Eur J Obstet Gynecol Reprod Biol 2008; 139:59-64.
  • [16]Agarwal A,Venkat A.Questionnaire study on menstrual disorders in adolescent girls in Singapore.J Pediatr Adolesc Gyneco12009; 22:365-371.
  • [17]Pillay OC,Te Fong LF,Crow JC,Benjamin E,Mould T.The association between polycystic ovaries and endometrial cancer.Hum Reprod 2006; 21:924-929.
  • [18]Azziz R.Diagnostic criteria for polycystic ovary syndrome:a reappraisal.Fertil Steril 2005; 83:1343-1346.
  • [19]Azziz R.Controversy in clinical endocrinology:diagnosis of polycystic ovarian syndrome:the Rotterdam criteria are premature.J Clin Endocrinol Metab 2006; 91:781-785.
  • [20]Hassa H,Tanir HM,Yildiz Z.Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.Arch Gynecol Obstet 2006; 274:227-232.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn